Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Gutiérrez González, Raquel ^a   Boto, Gregorio R ^a   Fernández Pérez, Cristina ^a   del Prado, Náyade ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN MALFORMATION; BRAIN TUMOR; CATHETER INFECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID DIVERSION; CEREBROSPINAL FLUID SHUNTING; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; DEVICE; DEVICE INFECTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INDEPENDENT VARIABLE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NORMOTENSIVE HYDROCEPHALUS; PRESCHOOL CHILD; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; TRAUMATIC BRAIN INJURY; VASCULAR DISEASE; COHORT ANALYSIS; INDWELLING CATHETER; INSTRUMENTATION; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; YOUNG ADULT;

EID: 77957734396     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-93     Document Type: Article

References (41)

1. Blount JP, Campbell JA, Haines SJ. Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 1993, 4:633-656.
2. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995, 136:1-7. 10.1007/BF01411427, 8748819.
3. George R, Leibrock L, Epstein M. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 1979, 51:804-811. 10.3171/jns.1979.51.6.0804, 501424.
4. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Schiff S, Cochrane D, Steinbok P, MacNeil N. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000, 33:230-236. 10.1159/000055960, 11155058.
5. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, Walker ML. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006, 105(Suppl 3):177-181.
6. Lenfestey RW, Smith PB, Moody MA, Clark RH, Cotten CM, Seed PC, Benjamin DK. Predictive value of cerebrospinal fluid parameters in neonates with intraventricular drainage devices. J Neurosurg 2007, 107(Suppl 3):209-212.
7. Lyke KE, Obasanjo OO, Williams MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 2001, 33:2028-2033. 10.1086/324492, 11712094.
8. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975, 131:543-552.
9. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984, 60:1014-1021. 10.3171/jns.1984.60.5.1014, 6716136.
10. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, Chuang YC, Liliang PC, Su TM, Rau CS, Tsai YD, Cheng BC, Hung PL, Chang CJ, Lu CH. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcome. Jpn J Infect Dis 2004, 57:44-48.
11. Albanese A, De Bonis P, Sabatino G, Capone G, Marchese E, Vignati A, Maira G. Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 2009, 151:1259-1263. 10.1007/s00701-009-0317-2, 19390777.
12. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 2005, 21:56-61. 10.1007/s00381-004-1052-x, 15480705.
13. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010, 66:284-289. 10.1227/01.NEU.0000363405.12584.4D, 20087127.
14. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatrics 2008, 1:444-450.
15. Eymann R, Steudel WI, Kiefer M. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis. Klin Padiatr 2009, 221:69-73. 10.1055/s-0028-1119397, 19263325.
16. Govender ST, Nathoo N, van Deller JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003, 99:831-839. 10.3171/jns.2003.99.5.0831, 14609161.
17. Gutiérrez-González R, Boto GR, González N, Viudez I, Pérez-Zamarrón A, Rivero-Garvía M. Effect of antibiotic-impregnated catheters on the incidence of infection after cerebrospinal fluid shunting. Med Clin (Barc) 2008, 131:121-124. 10.1157/13124097, 18601822.
18. Gutierrez-Gonzalez R, Boto GR. Do antibiotic-impreganted catheters prevent infection in CSF diversion procedures? Review of the literature. J Infect 2010, 61:9-20. 10.1016/j.jinf.2010.03.030, 20363252.
19. Hampl JA, Weitzel A, Bonk C, Kohnen W, Roesner D, Jansen B. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003, 31:109-111. 10.1007/s15010-002-2113-2, 12682816.
20. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008, 24:557-562. 10.1007/s00381-007-0521-4, 17962953.
21. Izci Y, Secer H, Akay C, Gonul E. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res 2008, 31:234-237. 10.1179/174313209X380973, 19040800.
22. Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infection in children. Childs Nerv Syst 2007, 23:773-777. 10.1007/s00381-007-0296-7, 17285349.
23. Kaufmann AM, Lye T, Redekop G, Brevner A, Hamilton M, Kozey M, Easton D. Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 2004, 31:506-510.
24. Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C, Pfausler B, Brenneis C, Huck C, Engelhardt K, Obwegeser AA, Schmutzhard E. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008, 8:360-365. 10.1007/s12028-008-9071-1, 18320144.
25. Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, Carson B, Jallo GI. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 2009, 25:77-83. 10.1007/s00381-008-0743-0, 18985357.
26. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 2007, 14:526-531. 10.1016/j.jocn.2006.11.003, 17430776.
27. Richards HK, Seeley HM, Pickard JD. Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from de United Kingdom Shunt Registry. J Neurosurg Pediatr 2009, 4:389-393. 10.3171/2009.4.PEDS09210, 19795972.
28. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007, 7:38. 10.1186/1471-2334-7-38, 1888699, 17488498.
29. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 2005, 103(Suppl 2):131-136.
30. Sciubba DM, Lin L, Woodworth GF, McGirth MJ, Carson B, Jallo GI. Factors contributing the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 2007, 22:E9. 10.3171/foc.2007.22.4.11, 17613199.
31. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 2007, 23:867-871. 10.1007/s00381-007-0334-5, 17387486.
32. Sciubba DM, Noggle JC, Carson BS, Jallo GI. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg 2008, 44:91-96. 10.1159/000113109, 18230921.
33. Sloffer CA, Augspurger L, Wagenbach A, Lanzino G. Antimicrobial-impregnated external ventricular catheters: does the very low infection rate observed in clinical trials apply to daily clinical practice?. Neurosurgery 2005, 56:1041-1044.
34. Tamburrini G, Massimi L, Caldarelli M, Di Rocco C. Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 2008, 150:1049-1056. 10.1007/s00701-008-0022-6, 18777004.
35. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003, 98:725-730. 10.3171/jns.2003.98.4.0725, 12691395.
36. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989, 52:605-609. 10.1136/jnnp.52.5.605, 1032173, 2732730.
37. Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997, 87:247-251. 10.3171/jns.1997.87.2.0247, 9254088.
38. Gower DJ, Gower VC, Richardson SH, Kelly DL. Reduced bacterial adherence to silicone plastic neurosurgical prosthesis. Pediatr Neurosci 1985, 12:127-133. 10.1159/000120247, 3843255.
39. Bayston R, Penny S. Excessive production of mucoid substance in staphylococcus SIIA: a possible factor in colonisation of holter shunts. Dev Med Child Neurol Suppl 1972, 27:25-28.
40. Bayston R, Barsham S. Catheter colonisation: a laboratory model suitable for aetiological, therapeutic and preventive studies. Med Lab Sci 1988, 45:235-239.
41. Stevens EA, Palavecino E, Sherertz RJ, Shihabi Z, Couture DE. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J Neurosurg 2010, 113(1):86-92. 10.3171/2009.10.JNS09565, 19961313.